T1	Participants 92 170	599 evaluable patients with benign prostatic hypertrophy at 7 urological units
T2	Participants 211 249	patients were randomized into 3 groups
T3	Participants 443 579	Patients with a preoperative indwelling catheter, positive urine culture, signs of active infection or preoperative antibiotic treatment
